• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型控释聚乳酸-羟基乙酸共聚物-海藻酸盐-果胶酸盐多球体药物递送系统的设计与开发

Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.

作者信息

Sweet Joe L, Pillay Viness, Choonara Yahya E

机构信息

Webster Surgical Center, Tallahassee, Florida, USA.

出版信息

Drug Deliv. 2007 Jul;14(5):309-18. doi: 10.1080/10717540701203067.

DOI:10.1080/10717540701203067
PMID:17613019
Abstract

A 23 full factorial design was employed to evaluate and optimize the drug entrapment efficiency and in vitro drug release from PLGA microparticles encapsulated in a complex crosslinked alginate-pectinate matrix (polysphere). The independent formulation variables included the volume of internal and external phases, and concentration of PLGA. Surface morphology and internal structure of PLGA microparticles and polyspheres were examined by scanning electron microscopy which revealed spherical PLGA microparticles with highly porous surfaces that accounted for the rapid burst effect of this system. Texture analysis was used to profile the matrix resilience, tolerance, and energy absorbed. In vitro drug release was assessed in buffer media on PLGA microparticles and polyspheres. Polyspheres exhibited ideal zero-order release while PLGA microparticles had a burst effect followed by lag phase. Kinetic modeling of in vitro drug release data indicated that formulations were not highly dependent on polymeric erosion as a mechanism for drug release but rather diffusion. A close correlation existed between the matrix tolerance and energy absorbed. Formulations with decreased tolerance absorbed less energy, thus led to rapid surface erosion, lower matrix integrity and hence a burst effect. The converse was true for an increased matrix tolerance, which led to zero-order release supported by superior matrix integrity and a significantly reduced burst effect. The rat subcutaneous model validated in vitro release data and demonstrated that the polyspheres provided flexible yet superior rate-modulated drug delivery.

摘要

采用23全因子设计来评估和优化包裹在复合交联藻酸盐 - 果胶酸盐基质(多球体)中的PLGA微粒的药物包封效率和体外药物释放。独立的配方变量包括内相和外相的体积以及PLGA的浓度。通过扫描电子显微镜检查PLGA微粒和多球体的表面形态和内部结构,结果显示PLGA微粒呈球形,表面具有高度多孔性,这解释了该系统的快速突释效应。使用质地分析来描述基质的弹性、耐受性和吸收的能量。在缓冲介质中对PLGA微粒和多球体进行体外药物释放评估。多球体表现出理想的零级释放,而PLGA微粒则有一个突释效应,随后是滞后阶段。体外药物释放数据的动力学模型表明,制剂对作为药物释放机制的聚合物侵蚀的依赖性不高,而对扩散的依赖性较高。基质耐受性与吸收的能量之间存在密切相关性。耐受性降低的制剂吸收的能量较少,从而导致表面快速侵蚀、较低的基质完整性,进而产生突释效应。相反,基质耐受性增加时情况则相反,这导致了零级释放,其支持因素是卓越的基质完整性和显著降低的突释效应。大鼠皮下模型验证了体外释放数据,并表明多球体提供了灵活且卓越的速率调节药物递送。

相似文献

1
Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.新型控释聚乳酸-羟基乙酸共聚物-海藻酸盐-果胶酸盐多球体药物递送系统的设计与开发
Drug Deliv. 2007 Jul;14(5):309-18. doi: 10.1080/10717540701203067.
2
Formulation and statistical optimization of novel double-incorporated PLA-PLGA microparticles within an alginate-pectinate platform for the delivery of nicotine.用于尼古丁递送的藻酸盐-果胶酸盐平台内新型双重包埋PLA-PLGA微粒的制剂与统计优化
J Microencapsul. 2006 Mar;23(2):153-67. doi: 10.1080/02652040500435139.
3
Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.包衣聚合物微粒在组织工程支架中的控释。
J Drug Target. 2001;9(6):431-8. doi: 10.3109/10611860108998777.
4
Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.载酮咯酸氨丁三醇的可生物降解微球的制剂、表征及评价
Drug Deliv. 2005 May-Jun;12(3):133-9. doi: 10.1080/10717540590925726.
5
Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium.载有双氯芬酸钠的 Eudragit® L100 和 Eudragit® L100-PLGA 纳米粒的配方和体外特性研究。
AAPS PharmSciTech. 2010 Sep;11(3):1250-6. doi: 10.1208/s12249-010-9489-6. Epub 2010 Aug 10.
6
Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.载胰岛素聚(丙烯酰羟乙基淀粉)-聚乳酸-羟基乙酸共聚物复合微球的制备及体内外评价
Pharm Res. 2003 Mar;20(3):452-9. doi: 10.1023/a:1022668507748.
7
Fabrication and characterization of monodisperse PLGA-alginate core-shell microspheres with monodisperse size and homogeneous shells for controlled drug release.制备并表征具有单分散尺寸和均匀壳层的 PLGA-海藻酸钠核壳微球用于控制药物释放。
Acta Biomater. 2013 Jul;9(7):7410-9. doi: 10.1016/j.actbio.2013.03.022. Epub 2013 Mar 25.
8
Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.通过添加聚(D,L-丙交酯)低聚物来调节聚(D,L-丙交酯-共-乙交酯)微球中碘苷的释放。
J Control Release. 1999 Apr 19;58(3):311-22. doi: 10.1016/s0168-3659(98)00165-5.
9
Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.负载胰岛素的可生物降解聚乳酸-羟基乙酸共聚物微胶囊:由亲水性添加剂控制的初始突释
J Control Release. 2002 Jun 17;81(3):235-49. doi: 10.1016/s0168-3659(02)00060-3.
10
Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics.酮洛芬-聚(D,L-乳酸-共-乙醇酸)微球:制备参数和聚合物类型对释放特性的影响
J Microencapsul. 1999 Jan-Feb;16(1):1-12. doi: 10.1080/026520499289266.

引用本文的文献

1
Drug-triggered and cross-linked self-assembling nanofibrous hydrogels.药物触发和交联的自组装纳米纤维水凝胶。
J Am Chem Soc. 2015 Apr 15;137(14):4823-30. doi: 10.1021/jacs.5b01549. Epub 2015 Apr 1.